News

News
Partner news

Vect-Horus Announces Agreement With Johnson & Johnson Innovation

Read full story
Partner news

ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

Read full story
Partner news

Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders

Read full story
Partner news

Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen

Read full story
Partner news

Carrot Inc. Raises $25 Million to Commercialize Pivot, the Company's Digital Health Solution for Smoking Cessation

Read full story
Partner news

Touchlight announces collaboration with Janssen Biotech

Read full story
Partner news

CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

Read full story
Partner news

Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen

Read full story
Partner news

BIO-Europe® Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

Read full story
Partner news

Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding

Read full story
Partner news

Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies

Read full story
Partner news

Provention Bio Announces Closing of Upsized Initial Public Offering

Read full story
Partner news

Asceneuron's Tau Modifier ASN120290 Receives Orphan Drug Designation for Progressive Supranuclear Palsy From the FDA

Read full story
Partner news

Cue Health Completes $45MM Series B Financing

Read full story
Partner news

Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression

Read full story